Jefferies ups Kendle price target to $41

Kendle International Inc. was reiterated at a buy with an increased price target of $41 by Jefferies & Co., Inc. analyst David Windley. The company's third-quarter net book-to-bill of 1.88 goes a long way toward easing the analyst's integration concerns. Kendle reported $0.33 per share on $75.2 million in revenue, compared with Windley's estimate of $0.32 on $75.9 million. Shares of the Cincinnati-based clinical research organization were down 82 cents, or 2.37%, at $33.80. (Nasdaq: KNDL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.